Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice
Top Cited Papers
- 4 January 2025
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 292 (2) , 468-479
- https://doi.org/10.1016/s0022-3565(24)35315-7
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Antisense oligonucleotides: Is the glass half full or half empty?Biochemical Pharmacology, 1998
- Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsToxicology, 1997
- Amplification of antibody production by phosphorothioate oligodeoxynucleotidesJournal of Laboratory and Clinical Medicine, 1996
- Effect of Antisense Oligonucleotides on Cytokine Release from Human Keratinocytes in anin VitroModel of SkinToxicology and Applied Pharmacology, 1996
- Effect of different chemically modified oligodeoxynucleotides on immune stimulationBiochemical Pharmacology, 1996
- Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.Journal of Biological Chemistry, 1994
- Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virusLife Sciences, 1994
- Evaluation of 2‘-modified oligonucleotides containing 2‘-deoxy gaps as antisense inhibitors of gene expressionJournal of Biological Chemistry, 1993
- Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1Biochemical Pharmacology, 1993
- Advances in the Synthesis of Oligonucleotides by the Phosphoramidite ApproachTetrahedron, 1992